Related content

Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy?

By Sang D.  

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1570-1573

Springer Publishing Company

Access to resources Recommend Favorite

Role of Cytokines and Trophic Factors in the Pathogenesis of Diabetic Retinopathy

By  

Current Diabetes Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 73-81

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy

By García-Ramírez M.   Canals F.   Hernández C.   Colomé N.   Ferrer C.   Carrasco E.   García-Arumí J.   Simó R.  

Diabetologia, Vol. 50, Iss. 6, 2007-06 ,pp. : 1294-1303

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of epithelial growth factor receptor signalling does not preserve epithelial barrier function after in vitro gliadin insult

By Juuti-Uusitalo Kati   Lindfors Katri   Maki Markku   Patrikainen Mimmi   Isola Jorma   Kaukinen Katri  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 7, 2009-07 ,pp. : 820-825

Informa Healthcare

Access to resources Recommend Favorite

The Potential Role of Octreotide in the Treatment of Diabetic Retinopathy

By Grant Maria B.   Sergio Caballero Jr  

Treatments in Endocrinology, Vol. 4, Iss. 4, 2005-01 ,pp. : 199-203

Adis International

Access to resources Recommend Favorite